Viewpoint: Therapeutic implications of CTLA-4 compartmentalization

American Journal of Transplantation

Volumn 3, Issue 8, 2003, Pages 919-926

  Baroja, Miren L ^a   Madrenas, Joaquín ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

CTLA 4; Immune tolerance; T cell activation; Transplantation

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ALLOGRAFT; AUTOIMMUNE DISEASE; CELL COMPARTMENTALIZATION; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; NONHUMAN; ORGAN TRANSPLANTATION; SHORT SURVEY; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CELL COMPARTMENTATION; HUMANS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0042265184     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.00182.x     Document Type: Short Survey

References (76)

1. Schwartz JC, Zhang X, Nathenson SG, Almo SC. Structural mechanisms of costimulation. Nat Immunol 2002; 3: 427-434.
2. Egen JG, Kuhns MS, Allison JP. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 2002; 3: 611-618.
3. Carreno BM, Collins M. The B7 family of ligands and its receptors: new pathways for costimutation and inhibition of immune responses. Annu Rev Immunol 2002; 20: 29-53.
4. Collins AV, Brodie DW, Gilbert RJ et al. The interaction properties of costimulatory molecules revisited. Immunity 2002; 17: 201-210.
5. Grakoui A, Bromley SK, Sumen C et al. The immunological synapse: a molecular machine controlling T cell activation. Science 1999; 285: 221-227.
6. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997; 387: 569-572.
7. Frauwirth KA, Thompson CB. Activation and inhibition of lymphocytes by costimulation. J Clin Invest 2002; 109: 295-299.
8. Greenwald RJ, Latchman YE, Sharpe AH. Negative co-receptors on lymphocytes. Curr Opin Immunol 2002; 14: 391-396.
9. Bour-Jordan H, Blueston JA. CD28 function: a balance of costimulatory and regulatory signals. J Clin Immunol 2002; 22: 1-7.
10. Carreno BM, Bennett F, Chau TA et al. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J Immunol 2000; 165: 1352-1356.
11. Riley JL, Mao M, Kobayashi S et al. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc Natl Acad Sci USA 2002; 99: 11790-11795.
12. Ostrov DA, Shi W, Schwartz JC, Almo SC, Nathenson SG. Structure of murine CTLA-4 and its role in modulating T cell responsiveness. Science 2000; 290: 816-819.
13. Stamper CC, Zhang Y, Tobin JF et al. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature 2001; 410: 608-611.
14. Schwartz JC, Zhang X, Fedorov AA, Nathenson SG, Almo SC. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature 2001; 410: 604-608.
15. Nakaseko C, Miyatake S, Iida T et al. Cytotoxic T lymphocyte antigen 4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tail. J Exp Med 1999; 190: 765-774.
16. Baroja ML, Luxenberg D, Chau T et al. The inhibitory function of CTLA-4 does not require its tyrosine phosphorylation. J Immunol 2000; 164: 49-55.
17. Cinek T, Sadra A, Imboden JB. Cutting edge: tyrosine-independent transmission of inhibitory signals by CTLA-4. J Immunol 2000; 164: 5-8.
18. Masteller EL, Chuang E, Mullen AC, Reiner SL, Thompson CB. Structural analysis of CTLA-4 function in vivo. J Immunol 2000; 164: 5319-5327.
19. Shiratori T, Miyatake S, Ohno H et al. Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2. Immunity 1997; 6: 583-589.
20. Zhang Y, Allison JP. Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein. Proc Natl Acad Sci USA 1997; 94: 9273-9278.
21. Chuang E, Alegre ML, Duckett CS, Noel PJ, Vander Heiden MG, Thompson CB. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. J Immunol 1997; 159: 144-151.
22. Perez VL, Van Parijs L, Biuckians A, Zheng XX, Strom TB, Abbas AK. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 1997; 6: 411-417.
23. Wells AD, Walsh MC, Bluestone JA, Turka LA. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J Clin Invest 2001; 108: 895-903.
24. Greenwald RJ, Boussiotis VA, Lorsbach RB, Abbas AK, Sharpe AH. CTLA-4 regulates induction of anergy in vivo. Immunity 2001; 14: 145-155.
25. Linsley PS, Nadler SG, Bajorath J et al. Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). A disulfide-linked homodimer binds two CD86 molecules. J Biol Chem 1995; 270: 15417-15424.
26. Walunas TL, Bakker CY, Bluestone JA. CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 1996; 183: 2541-2550.
27. Pioli C, Gatta L, Frasca D, Doria G. Cytotoxic T lymphocyte antigen 4 (CTLA-4) inhibits CD28-induced IkappaBalpha degradation and RelA activation. Eur J Immunol 1999; 29: 856-863.
28. Delon J, Kaibuchi K, Germain RN. Exclusion of CD43 from the immunological synapse is mediated by phosphorylation-regulated relocation of the cytoskeletal adaptor moesin. Immunity 2001; 15: 691-701.
29. Bromley SK, Burack WR, Johnson KG et al. The immunological synapse. Annu Rev Immunol 2001; 19: 375-396.
30. van Der Merwe PA, Davis SJ. Immunology. The immunological synapse - a multitasking system. Science 2002; 295: 1479-1480.
31. Lee KH, Holdorf AD, Dustin ML, Chan AC, Allen PM, Shaw AS. T cell receptor signaling precedes immunological synapse formation. Science 2002; 295: 1539-1542.
32. Blanchard N, Di Bartolo V, Hivroz C. In the immune synapse, ZAP-70 controls T cell polarization and recruitment of signaling proteins but not formation of the synaptic pattern. Immunity 2002; 17: 389-399.
33. Dustin ML, Colman DR. Neural and immunological synaptic relations. Science 2002; 298: 785-789.
34. Davis SJ, van der Merwe PA. The immunological synapse: required for T cell receptor signalling or directing T cell effector function? Curr Biol 2001; 11: 289-291.
35. Lee SJ, Hori Y, Groves JT, Dustin ML, Chakraborty AK. Correlation of a dynamic model for immunological synapse formation with effector functions: two pathways to synapse formation. Trends Immunol 2002; 23: 492-499.
36. Radoja S, Saio M, Schaer D, Koneru M, Vukmanovic S, Frey AB. CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis. J Immunol 2001; 167: 5042-5051.
37. Viola A. The amplification of TCR signaling by dynamic membrane microdomains. Trends Immunol 2001; 22: 322-327.
38. Cherukuri A, Dykstra M, Pierce SK. Floating the raft hypothesis: lipid rafts play a role in immune cell activation. Immunity 2001; 14: 657-660.
39. Xavier R, Brennan T, Li Q, McCormack C, Seed B. Membrane compartmentation is required for efficient T cell activation. Immunity 1998; 8: 723-732.
40. Germain RN. The T cell receptor for antigen: signaling and ligand discrimination. J Biol Chem 2001; 276: 35223-35226.
41. Stoddart A, Dykstra ML, Brown BK, Song W, Pierce SK, Brodsky FM. Lipid rafts unite signaling cascades with clathrin to regulate BCR internalization. Immunity 2002; 17: 451-462.
42. Linsley PS, Bradshaw J, Greene J, Peach R, Bennett KL, Mittler RS. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 1996; 4: 535-543.
43. Egen JG, Allison JP. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 2002; 16: 23-35.
44. Darlington PJ, Baroja ML, Chau TA et al. Surface cytotoxic T lymphocyte-associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation. J Exp Med 2002; 195: 1337-1347.
45. Chikuma S, Imboden JB, Bluestone JA. Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2003; 197: 129-135.
46. Demetriou M, Granovsky M, Quaggin S, Dennis JW. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 2001; 409: 733-739.
47. Lee KM, Chuang E, Griffin M et al. Molecular basis of T cell inactivation by CTLA-4. Science 1998; 282: 2263-2266.
48. Calvo CR, Amsen D, Kruisbeek AM. Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70. J Exp Med 1997; 186: 1645-1653.
49. Zhang W, Trible RP, Samelson LE. LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity 1998; 9: 239-246.
50. Chuang E, Fisher TS, Morgan RW et al. The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A. Immunity 2000; 13: 313-322.
51. Baroja ML, Vijayakrishnan L, Bettelli E et al. Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A. J Immunol 2002; 168: 5070-5078.
52. Martin M, Schneider H, Azouz A, Rudd CE. Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function. J Exp Med 2001; 194: 1675-1681.
53. Dupre L, Aiuti A, Trifari S et al. Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity 2002; 17: 157-166.
54. Raab M, Pfister S, Rudd CE. CD28 signaling via VAV/SLP-76 adaptors: regulation of cytokine transcription independent of TCR ligation. Immunity 2001; 15: 921-933.
55. Wulfing C, Davis MM. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science 1998; 282: 2266-2269.
56. Viola A, Schroeder S, Sakakibara Y, Lanzavecchia A. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 1999; 283: 680-682.
57. Michel F, Attal-Bonnefoy G, Mangino G, Mise-Omata S, Acuto O. CD28 as a molecular amplifier extending TCR ligation and signaling capabilities. Immunity 2001; 15: 935-945.
58. Lin H, Rathmell JC, Gray GS, Thompson CB, Leiden JM, Alegre ML. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice. CTLA4 can function independently of CD28. J Exp Med 1998; 188: 199-204.
59. Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001; 19: 225-252.
60. Yamada A, Kishimoto K, Dong VM et al. CD28-independent costimulation of T cells in alloimmune responses. J Immunol 2001; 167: 140-146.
61. Mandelbrot DA, Oosterwegel MA, Shimizu K et al. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4. J Clin Invest 2001; 107: 881-887.
62. Fecteau S, Basadonna GP, Freitas A, Ariyan C, Sayegh MH, Rothstein D. CTLA-4 up-regulation plays a role in tolerance mediated by CD45. Nat Immunol 2001; 2: 58-63.
63. Grohmann U, Orabona C, Fallarino F et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 2002; 3: 1097-1101.
64. Metz DP, Farber DL, Taylor T, Bottomly K. Differential role of CTLA-4 in regulation of resting memory versus naive CD4 T cell activation. J Immunol 1998; 161: 5855-5861.
65. Bour-Jordan H, Grogan JL, Tang Q, Auger JA, Locksley RM, Bluestone JA. CTLA-4 regulates the requirement for cytokine-induced signals in T (H) 2 lineage commitment. Nat Immunol 2003; 4: 182-188.
66. Kato T, Nariuchi H. Polarization of naive CD4+ T cells toward the Th1 subset by CTLA-4 costimulation. J Immunol 2000; 164: 3554-3562.
67. Oosterwegel MA, Mandelbrot DA, Boyd SD et al. The role of CTLA-4 in regulating Th2 differentiation. J Immunol 1999; 163: 2634-2639.
68. Sho M, Yamada A, Najafian N et al. Physiological mechanisms of regulating alloimmunity: cytokines, CTLA-4, CD25+ cells, and the alloreactive T cell clone size. J Immunol 2002; 169: 3744-3751.
69. Iwakoshi NN, Mordes JP, Markees TG, Phillips NE, Rossini AA, Greiner DL. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner. J Immunol 2000; 164: 512-521.
70. Taylor PA, Noelle RJ, Blazar BR. CD4(+) CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001; 193: 1311-1318.
71. Griffin MD, Hong DK, Holman PO et al. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152). J Immunol 2000; 164: 4433-4442.
72. Frauwirth KA, Riley JL, Harris MH et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 2002; 16: 769-777.
73. Schneider H, Martin M, Agarraberes FA et al. Cytolytic T lymphocyte-associated antigen-4 and the TCR zeta/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2. J Immunol 1999; 163: 1868-1879.
74. Oki S, Kohsaka T, Azuma M. Augmentation of CTLA-4 expression by wortmannin: involvement of lysosomal sorting properties of CTLA-4. Int Immunol 1999; 11: 1563-1571.
75. Barrat FJ, Le Deist F, Benkerrou M et al. Defective CTLA-4 cycling pathway in Chediak-Higashi syndrome: a possible mechanism for deregulation of T lymphocyte activation. Proc Natl Acad Sci USA 1999; 96: 8645-8650.
76. Millward TA, Zolnierowicz S, Hemmings BA. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 1999; 24: 186-191.